140 related articles for article (PubMed ID: 17697999)
1. Ligand-induced structural transitions in ErbB receptor extracellular domains.
Dawson JP; Bu Z; Lemmon MA
Structure; 2007 Aug; 15(8):942-54. PubMed ID: 17697999
[TBL] [Abstract][Full Text] [Related]
2. Two EGF molecules contribute additively to stabilization of the EGFR dimer.
Lemmon MA; Bu Z; Ladbury JE; Zhou M; Pinchasi D; Lax I; Engelman DM; Schlessinger J
EMBO J; 1997 Jan; 16(2):281-94. PubMed ID: 9029149
[TBL] [Abstract][Full Text] [Related]
3. The extracellular domains of ErbB3 retain high ligand binding affinity at endosome pH and in the locked conformation.
Kani K; Park E; Landgraf R
Biochemistry; 2005 Dec; 44(48):15842-57. PubMed ID: 16313187
[TBL] [Abstract][Full Text] [Related]
4. A structure-based model for ligand binding and dimerization of EGF receptors.
Klein P; Mattoon D; Lemmon MA; Schlessinger J
Proc Natl Acad Sci U S A; 2004 Jan; 101(4):929-34. PubMed ID: 14732694
[TBL] [Abstract][Full Text] [Related]
5. Structure of the extracellular region of HER3 reveals an interdomain tether.
Cho HS; Leahy DJ
Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface.
Dawson JP; Berger MB; Lin CC; Schlessinger J; Lemmon MA; Ferguson KM
Mol Cell Biol; 2005 Sep; 25(17):7734-42. PubMed ID: 16107719
[TBL] [Abstract][Full Text] [Related]
7. Oligomers of ERBB3 have two distinct interfaces that differ in their sensitivity to disruption by heregulin.
Kani K; Warren CM; Kaddis CS; Loo JA; Landgraf R
J Biol Chem; 2005 Mar; 280(9):8238-47. PubMed ID: 15611073
[TBL] [Abstract][Full Text] [Related]
8. The tethered configuration of the EGF receptor extracellular domain exerts only a limited control of receptor function.
Mattoon D; Klein P; Lemmon MA; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2004 Jan; 101(4):923-8. PubMed ID: 14732693
[TBL] [Abstract][Full Text] [Related]
9. On the nature of low- and high-affinity EGF receptors on living cells.
Ozcan F; Klein P; Lemmon MA; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5735-40. PubMed ID: 16571657
[TBL] [Abstract][Full Text] [Related]
10. Active and inactive conformations of the epidermal growth factor receptor.
Ferguson KM
Biochem Soc Trans; 2004 Nov; 32(Pt 5):742-5. PubMed ID: 15494003
[TBL] [Abstract][Full Text] [Related]
11. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab.
Li S; Schmitz KR; Jeffrey PD; Wiltzius JJ; Kussie P; Ferguson KM
Cancer Cell; 2005 Apr; 7(4):301-11. PubMed ID: 15837620
[TBL] [Abstract][Full Text] [Related]
13. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.
Ferguson KM; Berger MB; Mendrola JM; Cho HS; Leahy DJ; Lemmon MA
Mol Cell; 2003 Feb; 11(2):507-17. PubMed ID: 12620237
[TBL] [Abstract][Full Text] [Related]
14. Bivalence of EGF-like ligands drives the ErbB signaling network.
Tzahar E; Pinkas-Kramarski R; Moyer JD; Klapper LN; Alroy I; Levkowitz G; Shelly M; Henis S; Eisenstein M; Ratzkin BJ; Sela M; Andrews GC; Yarden Y
EMBO J; 1997 Aug; 16(16):4938-50. PubMed ID: 9305636
[TBL] [Abstract][Full Text] [Related]
15. Ligand binding induces a conformational change in epidermal growth factor receptor dimers.
Walker F; Rothacker J; Henderson C; Nice EC; Catimel B; Zhang HH; Scott AM; Bailey MF; Orchard SG; Adams TE; Liu Z; Garrett TP; Clayton AH; Burgess AW
Growth Factors; 2012 Dec; 30(6):394-409. PubMed ID: 23163584
[TBL] [Abstract][Full Text] [Related]
16. Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor.
Bessman NJ; Bagchi A; Ferguson KM; Lemmon MA
Cell Rep; 2014 Nov; 9(4):1306-17. PubMed ID: 25453753
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ
Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205
[TBL] [Abstract][Full Text] [Related]
18. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.
Odaka M; Kohda D; Lax I; Schlessinger J; Inagaki F
J Biochem; 1997 Jul; 122(1):116-21. PubMed ID: 9276679
[TBL] [Abstract][Full Text] [Related]
19. Role of N-glycosylation in EGFR ectodomain ligand binding.
Azimzadeh Irani M; Kannan S; Verma C
Proteins; 2017 Aug; 85(8):1529-1549. PubMed ID: 28486782
[TBL] [Abstract][Full Text] [Related]
20. Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis.
Stein RA; Staros JV
BMC Evol Biol; 2006 Oct; 6():79. PubMed ID: 17026767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]